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ABSTRACT
Development of synthetic molecules that can act in similar ways to biological
proteins capable of ion transport has become a topic of interest in many fields of
research. This thesis investigates the possibility of ion transport through the
incorporation of [2]rotaxane molecules into a lipid membrane.
Chapter 1 outlines the reasoning behind the development of a [2]rotaxane
with a T-shaped axle utilizing a benzimidazolium-based recognition site as a suitable
candidate for a synthetic anion transporter. It also highlights results of transport
studies from related benzimidazolium salts.
Chapter 2 outlines the synthesis of the desired T-shaped axle and its related
[2]rotaxane, with discussion of the various synthetic routes attempted. Results from
incorporation of both molecules into anion transport studies are discussed, with a
summary and future work also included.
Chapter 3 describes all of the experimental data. This includes the full
synthetic procedure for the preparation of both the T-shaped axle and related
[2]rotaxane, as well as the experimental setup for the transmembrane transport
assays conducted.
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CHAPTER 1 – Supramolecular Chemistry and Synthetic Anion Transporters
1.1 Introduction to Supramolecular Chemistry
Supramolecular chemistry has emerged as a multi-disciplinary field, drawing
from organic, coordination, and physical chemistry, as well as biology, to develop
complex chemical systems based on intermolecular interactions that are noncovalent in nature.1 This branch of chemistry was defined by Jean Marie Lehn in
1969 while studying inclusion complexes formed with cryptands,2 and was further
formalized when Lehn, Charles Pedersen, and Donald Cram were awarded the 1987
Nobel Prize in Chemistry for their discoveries in the field.3
The construction of supramolecular molecules relies on self-assembly. This is
a spontaneous process that is dependent on the information organized in the
structural building blocks of a molecule. It makes use of molecular recognition,
which allows multiple components to be positioned by non-covalent interactions,
and later potentially interlocked through covalent bond formation. Common noncovalent interactions that drive complexation include hydrogen bonding, π-π
stacking,

electrostatic

interactions,

hydrophobic

interactions

and

metal

coordination.4
1.1.1 Pseudorotaxanes and Rotaxanes
Pseudorotaxanes are an example of host-guest complexes prepared by
threading a macrocyclic ring, known as the wheel, onto a linear molecule, known as
the axle. The two components become positioned through favourable non-covalent
interactions, and the formed interpenetrated complex is in equilibrium with its
1

constituent components, as seen in Figure 1.1. When naming pseudorotaxanes, it is
important to include the sum of all the individual components that make up the
complex.

Therefore, when one linear axle is interpenetrated through one

macrocyclic ring, the resulting complex is said to be a [2]pseudorotaxane.

Figure 1.1: Representation of a linear axle and macrocyclic wheel in equilibrium with
a [2]pseudorotaxane

Pseudorotaxanes can be further modified to prevent the macrocyclic ring
from sliding off, creating what is called a [2]rotaxane. These complexes are
described as mechanically interlocked;5 they continue to be held together by noncovalent interactions, however the interaction is now permanent as a covalent bond
found in one of the components would have to be broken in order to return to its
constituent components. Rotaxanes can be prepared by two main synthetic
methods, capping6 or clipping.7 Figure 1.2a depicts the capping method, which
involves adding large bulky end groups onto the axle of a [2]pseudorotaxane to
prevent the macrocyclic ring from dissociating. The clipping method can be utilized
by first synthesizing an axle with bulky end groups (a dumbbell), and later
2

introducing an open macrocyclic precursor that can undergo a ring closing reaction
to interlock the ring around a recognition site on the axle, as shown in Figure 1.2b.

Figure 1.2: Representation of rotaxane synthesis via a) capping method and b)
clipping method

One application of [2]rotaxanes has included development of artificial
molecular machines (2016 Nobel Prize in Chemistry). By synthesizing axles with
multiple recognition sites, the position of the wheel can be influenced to undergo
translational motion either by chemical,8 electrochemical,9 or even photochemical
stimulation.10 Other applications include the use of [2]rotaxanes as sensors,11,12 and
transporters13 of charged ions.
1.1.2 The T-Shaped Benzimidazolium Axle
There are many templating motifs that can be incorporated into the axles of
interpenetrated and interlocked molecules to provide recognition sites for crown
ethers and other related guest molecules. Over the years, the Loeb research group
3

has focused on many different motifs such as 1,2-bis(pyridinium)ethane axles,14,15
N-benzylanilinium axles,16,17 and more recently, benzimidazolium axles.18,19
As

seen

in

Figure

1.3,

the

substitution

pattern

of

a

2,4,7-

triphenylbenzimidazolium ion provides a rare example of an organic molecule that
displays a rigid core with a 90° turn. It has
been shown by Loeb et al. that this Tshaped benzimidazolium axle provides
greater enhancement between a crown
ether wheel and axle when forming a
[2]pseudorotaxane, compared to simple
benzimidazolium

or

imidazolium

Figure 1.3: 2,4,7triphenylbenzimidazolium axle

cations.18
1.1.3 Intermolecular Interactions between Axle and Crown Ether Rings
The intermolecular interactions observed between an axle and a macrocyclic
ring in pseudorotaxanes and rotaxanes are non-covalent in nature. When crown
ether rings are used as the macrocyclic wheel, two types of hydrogen bonding
interactions between the wheel and axle can occur; NH⋯O interactions, as well as
CH⋯O interactions. Having a cationic charge on the benzimidazolium axle also
allows for ion-dipole interactions, such as N+⋯O, to aid in promoting axle and wheel
association.
One unique property of the T-shaped axle is the ability to utilize π-π
interactions to increase association with decorated crown ethers. For example,
4

dibenzo[24]crown-8 is a crown ether functionalized with aromatic groups that allow
the ring to fold and interact with the axle. As illustrated in Figure 1.4, the
contributions from all of these intermolecular interactions allow for the overall
enhancement of the T-shaped axle and wheel association.

Figure 1.4: Noncovalent interactions between 2,4,7-triphenylbenzimidazolium axle
and dibenzo[24]crown-8 wheel18
Use of this T-shaped motif has provided opportunity for a variety of
functionalized aromatics to be used on the axle. When R1 or R2 (as labelled in Figure
1.4) are electron withdrawing groups, the non-covalent interactions are
strengthened due to the increase in acidity of the hydrogen bond donors, as well as
the increased charge on the benzimidazolium rings.18 Conversely, using electron
donating groups in these positions will decrease the strength of the non-covalent
interactions, and therefore weaken the association between wheel and axle.
1.2 Anion Transport Across Cell Membranes
Many biological processes rely on molecular transport into or out of a cell to
function. In particular, one crucial molecule that requires transport is the chloride
5

ion (Cl-), as it is one of the most abundant anions found in the body. Chloride
transport across cell membranes is necessary for a variety of functions including
fluid transport, cell volume regulation, muscle contractions, and neuroexcitation.20
1.2.1 Cell Membranes
Cell membranes are composed of phospholipids that form bilayers which
separate the interior of a cell from the exterior environment. Cell membranes are
considered amphipathic due to the inherent structure of phospholipids; they are
composed of a phosphate group (polar head) attached to two fatty acid hydrocarbon
chains (nonpolar tails). However, due to the large composition of fatty acid chains,
the majority of the cell membrane is said to be nonpolar in nature.21
One of the major roles of a cellular membrane is to regulate the transport of
molecules required for survival. Membrane transport can be passive or active.
Passive transport, by diffusion or osmosis, occurs with no energy input and allows
hydrophobic or small, uncharged polar molecules to move down a concentration
gradient. The driving force is simply the difference in concentration between the
interior and exterior of the membrane. Passive transport is commonly experienced
by solutes such as O2, CO2, H2O and urea.21 Alternatively, active transport is coupled
to a metabolic energy source (i.e. ATP hydrolysis).21 This occurs when certain
solutes must be pumped either against a concentration or an electric potential
gradient.

6

1.2.2 Membrane Transport by Aid of Proteins
Sometimes, carrier or channel proteins are required to aid with both passive
and active membrane transport. Carrier protein transporters are usually lipophilic,
monomeric units capable of shuttling ionic guests from one side of the membrane to
the other side through the hydrophobic portion of the lipid bilayer. Conversely,
channel proteins are generally membrane-bound and span the length of the
membrane to provide passage of the small hydrophilic molecules from the
hydrophobic environment of the membrane. Both types of transport proteins are
essential for the transport of ions, as lipid bilayers are highly impermeable to
charged species.22

Figure 1.5: Comparison of transmembrane ion transport involving ion carriers and
ion channels; anions represented as red spheres22
Ion channel proteins can be classified based on their transport stoichiometry
and the direction of ion movement.22 Figure 1.6 depicts the three main modes of
transport through channel proteins. A uniport process occurs when a single ion is
carried across a membrane uni-directionally at a single time. Two different ions can
be transported simultaneously using co-transporters. Co-transporters that move
solutes in the same direction are known as symports, whereas movement of solutes
7

in the opposite direction is done through antiports. Co-transporters generally result
in electroneutral transport due to the transfer of equal amounts of positive and
negative charges.

Figure 1.6: Comparison of channel protein transport processes22
1.2.3 Mutations in Chloride Anion Transport
Unfortunately, natural carrier or channel proteins can become mutated and
result in negative effects on the transport of charged molecules across the
membrane. For example, malfunctioning chloride ion channels produce a deficiency
in the chloride transport process, and are responsible for diseases such as Bartter
syndrome, Dent’s disease, and cystic fibrosis.22 Cystic fibrosis (CF), which affects
approximately 70,000 people worldwide,23 is caused by a mutation in cystic fibrosis
transmembrane conductance regulator (CFTR) proteins. CFTR proteins are often
found embedded in the cell membranes of epithelial cells lining the lungs, pancreas,
and sweat glands to transport chloride anions.24 Once mutated, chloride and water
movement across epithelial membranes become compromised, depicted in Figure
1.7.
8

Figure 1.7: Comparison of chloride transport in normal and CF infected sweat duct
cells24
Epithelia with defective CFTR proteins develop thick, sticky mucus that coat
and clog ducts, collects in the lungs, and leads to lethal bacterial infections.25 To date,
the average life expectancy of a patient with CF is 40 years.23
1.2.4 The Development of Synthetic Anion Transporters
Since there is no cure for CF, the development of synthetic anion transporters
that can mimic the activity of functioning CFTR proteins and compensate for
chloride transport failure has become an area of focus for many research groups. It
is important to understand the chemistry behind natural protein transporters in
9

order to develop efficient synthetic mimics. Molecules that can be considered for
transport studies must be water-soluble for delivery to the cell, but also sufficiently
lipophilic for insertion into the cell membrane. Most synthetic anion transporters
are still only tested using liposomes as models, however the creation of transporters
that can function in vitro, as well as in vivo, is the ultimate goal.
There are many examples of supramolecular assemblies that are able to form
membrane-spanning channels and provide a pathway through which anions can
diffuse across. These channels utilize weak interactions, such as hydrogen bonding
or anion-π interactions, to transport anions across a lipid membrane.
One of the first anion-selective channels that utilized hydrogen bonding
interactions involved calix[4]arenes.26 Calix[4]arenes are attractive frameworks due
the possibility of functionalization, their rigidity, as well as their ability to bind
charged or neutral species. Work conducted by Davis et al. reported that
calix[4]arene tetrabutylamide was able to form ion channels in solution and
effectively transport HCl across liposomal membranes.26 Comparison of ion binding
and transport properties of calix[4]arene tetrabutylamide (Figure 1.8a) against
those of its analogues (Figure 1.8b), revealed that the compound’s hydrophobicity,
as well as the amide’s substitution pattern to allow for hydrogen bonding
interactions with the anion, were both essential for facilitating anion transport.
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Figure 1.8: a) Structure of calix[4]arene tetrabutylamide
b) Structure of calix[4]arene tetramethylamide, calix[4]arene octabutylamide,
and N-butyl-2-phenoxyacetamide (left to right respectively)26
Anion-π interactions have also been useful in developing synthetic anion
transporters. Matile et al. were able to demonstrate how oligo-(p-phenylene)-N-Nnapthalenediimide (O-NDI) rods were capable of utilizing multi-ion hopping to
selectively and effectively transport anions across lipid membranes.27 Multi-ion
hopping relies on multiple binding sites being present, and utilizes charge repulsion
to push ions through each site and across a membrane down a concentration
gradient (Figure 1.9).27 As an external chloride approaches the channel,
electrostatic repulsion causes one ion to move to a central site, causing further
repulsion to other internal ions. Eventually chloride ions that once occupied sites in
the channel are repelled out of the channel, and therefore through a cellular
membrane.
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Figure 1.9: Representation of multi-ion hopping27
Using DFT calculations, it was determined that tetramethylphenyl spacers
between three NDI acceptors would provide the appropriate length to span the
hydrophobic region of a common lipid membrane (approximately 30 Å).27 DFT
computed electrostatic potential maps also offered information about the
electrostatic properties and conformational arrangements of the O-NDI rods. As
seen in Figure 1.10, O-NDI rods provide continuous positive surfaces that have
varying intensity of electrostatic potential along different sites of the rods when the
tetramethylphenyl spacers are perpendicular to the NDI units.28 Therefore, O-NDI
systems can accomplish multi-ion hopping through both electrostatic and ioninduced polarization forces.
12

Figure 1.10: a) O-NDI rods aligning as anion-π slide
b)DFT computed electrostatic potential map for O-NDI rod; blue: electron-poor, red:
electron-rich28
Rods 1-1 – 1-5 (Figure 1.11) were tested in egg yolk phosphatidylcholine
large unilamellar vesicles (EYPC LUVs) that contained the pH-sensitive fluorescent
dye 8-hydroxy-1,3,6-pyrenetrisulfonate (HPTS), and were exposed to a pH gradient
with a base pulse.27 Upon addition of each rod, the change in HPTS emission was
observed and the velocity of decay of the pH gradient was monitored.
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Figure 1.11: O-NDI rods tested for anion transport27
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Rod 1-2 was found to have the highest activity. It was believed that having
one charged terminus provided the rod with the ability to be easily delivered to the
membrane as it was sufficiently water-soluble. Moreover, it was able to adapt an
active transmembrane structure due to the presence of a hydrophobic terminus. Rod
1-1 was found to have lower activity and precipitate prior to insertion of the
membrane due to the lack of charged termini, whereas rod 1-3, with both termini
charged, had excellent water-solubility but poor transmembrane orientation. Both
O-NDI hairpin structures 1-4 and 1-5 had very low activity for similar reasons.
It was determined that the activity of the rods did not change in response to
changing the cation, suggesting the mode of ion transport was not H+/M+ antiport.
Transport activity was affected however in response to changing the external anion,
and therefore believed that the mode of ion transport utilized Cl-/X- and Cl-/OHantiport.
Imidazolium salts have also been able to demonstrate controlled anion
transport activity, as shown by Schmitzer et al.29 Salts 1-5 - 1-7 (Figure 1.12), were
tested as transporters in EYPC liposomes loaded with the Cl- sensitive dye, lucigenin.
Upon addition of each salt, direct measurement of Cl- efflux could be monitored
based on the change of fluorescence emission from lucigenin.
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Figure 1.12: Imidazolium salts studied for anion transport activity29
Salt 1-8 was found to be the only active salt due to its ability to assemble in a
way that formed channels that spanned the length of the hydrophobic region of the
membrane. This was done by utilizing π-π stacking to induce directionality. Once in
the membrane, anion-π interactions allowed for multiion hopping across
hydrophobic region. Although salt 1-7 could be partitioned into the bilayer, it is
believed that this salt was not able to form strong aromatic interactions to create
channels that would span the length of the membrane (Figure 1.13).29 Finally, salt
1-6 was found to have the lowest transport activity, as it was extremely watersoluble, and could not be translocated into the membrane successfully.
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Figure 1.13: Computational modelling to show proposed alignment and self-assembly
of salts 1-7 and 1-8 in membrane; Br- counter ion in yellow, Cl- anion in red29

Salt 1-8 was further studied to investigate whether transport activity could
be controlled via the creation of inclusion complexes.29 α-Cyclodextrin (α-CD) and
cucurbit[7]uril (CB7) were used to create inclusion complexes with salt 1-8 by
accommodating the aromatic sidechains into their hydrophobic cavities. Both
inclusion complexes were found to be more water-soluble than the salt alone. The
formation of inclusion complexes allowed for the self-assembled channels to be
disrupted and lead to displacement of the salt from the membrane into the aqueous
phase, as seen in Figure 1.14.29 Therefore it was determined that anion transport
17

could be regulated through the creation of inclusion complexes between the salt and
nontoxic macrocycles.

Figure 1.14: Representation of the formation of inclusion complexes of salt 1-8 with
CB7 and α-CD, followed by displacement of transporter from the lipid bilayer29
Schmitzer’s group has also investigated the anionophoric activity of
2,4,7-triphenylbenzimidazole.30 Driven by the formation of hydrogen bonds and
stabilization through π-π stacking, the crystal structure of this motif shows the
formation of helical rods (Figure 1.15).
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Figure 1.15: Self-assembly of 2,4,7-triphenylbenzimidazole in the solid state showing
a) side view and b) top view of rod30
Although no open channels were formed, molecular modeling in an EYPC
bilayer confirmed the possibility of preserving the rod-like structure in the presence
of phospholipids for this molecule. As seen in Figure 1.16, four monomers of the
2,4,7-triphenylbezimidazole motif assembled in a rod-like helix which span the
thickness of the hydrophobic portion of a phospholipid membrane.30
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Figure 1.16: Molecular modelling results of 2,4,7-triphenylbenzimidazle in an EYPC
bilayer showing how a) four monomers provide the appropriate length to span the
hydrophobic region of membrane and b) possible sites for anion-π interactions30
Chloride transport studies were conducted using EYPC liposomes
encapsulated with lucigenin, and Cl- anions present in the extravesicular solution.
Upon addition of the transporter, the fluorescence of lucigenin decreased,
20

confirming Cl- transport into the liposome. To study the mechanism of transport,
studies were conducted in 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC)
liposomes. Phospholipids containing DPPC undergo a phase change at a temperature
of 41°C; below this temperature phospholipids are in a gel phase, while above this
temperature they are in a fluid phase.31 It is commonly observed that molecules that
act as mobile carriers show a reduction in chloride movement when placed in DPPC
liposomes, whereas transmembrane channels show no or slight variations in
activity. Upon testing 2.4.7-triphenylbenzimidazole in DPPC liposomes, only a slight
variation in transport activity was seen, therefore supporting the idea that this motif
formed transmembrane channels.30
1.2.5 Transmembrane Transport Assays for Synthetic Anion Transporters
Phospholipid vesicles provide strong models that can be used to understand
and study ion transport across cell membranes. Liposomes in particular offer great
versatility due to a large variety being available commercially and synthetically with
varying phospholipid composition. The intravesicular solution of liposomes is
dependent upon the solution that they were assembled in. The vesicles can then be
separated from the non-encapsulated material via dialysis or size-exclusion
chromatography, and later suspended in an extravesicular solution that contains
different components. This allows for creation of a transmembrane concentration
gradient, and ion transport facilitated by the addition of a transporter compound can
be monitored.22
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There are many different techniques that can be employed to monitor anion
transport processes. One common technique is the use of a fluorescence-based assay
which monitors changes in fluorescence emission of particular dyes (Figure 1.17)
based on changes in intravesicular pH, anion concentration, or electric potential.22
By encapsulating the probe in a liposome, the change in intravesicular anion
composition can be monitored over time.

Figure 1.17: Common dyes used to monitor ion transport in liposomal assays22
Lucigenin, a bis-acridiunium dication, is a commonly used fluorogenic probe
that can directly monitor anion transfer. Since the fluorescence of this dye is
quenched in the presence of halide anions but is insensitive to oxoanions such as
nitrate, phosphate, or sulfate, it is extremely useful for monitoring NO3-/Clexchange.32
Ion-selective electrodes (ISE) can also be used as a direct method to measure
ion transport processes, since the internal contents of liposomes are initially not
detected.22 Upon the addition of a transporter, efflux of ions into the extravesicular
solution results in a change of voltage that can be detected by the ISE. When using a
chloride selective ISE, nitrate can easily exchange with chloride due to its relatively
22

high lipophilicity, and therefore is often chosen as the external anion in the
surrounding buffer solution. It is optimal to use ISEs to measure ion transport when
synthetic transporters display fluorescence emission, especially in the range of
common fluorogenic probes.
1.3 Scope of Thesis
This thesis describes the synthesis of a new benzimidazole-based T-shaped
axle and its related [2]rotaxane for investigation of their anion transport
capabilities.

Based

on

anion

transport

studies

completed

on

previous

benzimidazolium salts, it has become evident molecules with higher lipophilicity are
generally capable of being more efficient anion transporters across phospholipid
membranes. This has led to the interest of developing hydrophobic molecules that
are capable of interacting with anions such as chloride through hydrogen bonding
and anion-π interactions.
The 2,4,7-triphenylbenzimidazole motif depicted in Figure 1.3 was originally
designed by the Loeb research group as an axle template for pseudorotaxanes, but
has since been tested as an anion transporter. In an effort to increase anion
transport efficiency, modification of this axle to a more lipophilic molecule was
believed to be a possible solution. A new dumbbell (Figure 1.18) was designed to
include an extension of the previous axle by addition of a phenyl ring, as well as
methyl substituents to act as bulky stopper groups. Formation of an analogous
[2]rotaxane could then become possible using the clipping methodology; in

23

particular utilizing ring-closing metathesis (RCM) to form a 24-crown-6 macrocyclic
ring developed in the Loeb group previously.

Figure 1.18: Target axle and [2]rotaxane for anion transport studies
Both free axle and [2]rotaxane should provide hydrophobic surfaces capable of
anion-π interactions similar to the previously tested and structurally related
benzimidazole molecules. The difference between these two molecules lies in the
availability of the N-H of the benzimidazole, as the macrocyclic wheel of the
[2]rotaxane will interact with that site on the axle, and be less available for chloride
interaction. This will allow for investigation into the formation of hydrogen bonding
interactions with chloride anions, and their importance in the ion transport process.
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CHAPTER 2 – Results and Discussion
2.1 Organic Synthesis
Synthesis of both the axle and [2]rotaxane involved a multistep reaction
pathway. Multiple pathways were tested and are discussed below.
2.1.1 Analysis of Synthetic Scheme #1
Synthetic Scheme #1 (Figure 2.1) was initially followed in hopes of obtaining
compound 7 through a condensation reaction between compounds 3 and 6, and
further synthesizing axle 8 via a Sonogashira cross coupling reaction.
The synthesis of 3 was first accomplished via bromination of 3,5dimethylaniline with NBS to produce compound 1, which subsequently underwent a
Sandmeyer reaction yielding compound 2. By performing a lithium-halogen
exchange reaction on 2, compound 3 was obtained in moderate yields. Lithiumhalogen exchanges occur between organohalide and organolithium species at
extremely fast rates, with the trend of exchange favouring I > Br > Cl > F.33
Compound 2 contains two sites for possible exchange. Although the site with
bromine is more sterically hindered, and not as favoured as the site with iodine, it is
possible some exchange occurred here, ultimately leading to a lower yield of the
desired compound 3.
Compound 6 was obtained by first brominating 2,1,3-benzothiadiazole using
molecular bromine in HBr to yield the disubstituted compound 4. This was followed
by a Suzuki coupling reaction using phenylboronic acid, Cs2CO2, and Pd(PPh3)4 as a
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catalyst to yield compound 5, with subsequent reductive extrusion of sulfur using
NaBH4 and CoCl2 catalyst to produce compound 6 as the diamine product.

Figure 2.1: Synthetic Scheme #1
26

Since the diamine product is air-sensitive, it was important for this product to
be used in the condensation reaction immediately, or otherwise be stored under an
inert nitrogen atmosphere. Compounds 3 and 6 underwent a condensation reaction
using ZrCl4 as a catalyst to yield compound 7. This molecule was designed to provide
a template for a new T-shaped axle by using the bromine substituent as a site for
further functionalization.
A Sonogashira cross-coupling reaction was attempted between compound 7
and phenylacetylene using CuI and PdCl2(PPh3)2 as catalysts, and PPh3 to activate
the palladium catalyst. Although the crude product was subjected to column
chromatography using a variety of solvent gradients, compound 8 was never
isolated pure. 1H NMR spectroscopy showed many proton environments relating to
compound 7, suggesting that a Sonogashira reaction between compound 7 and
phenylacetylene was not ideal, and the crude product contained much of the original
starting material. Further analysis using IR spectroscopy supported the idea that
compound 8 was not successfully synthesized due to the lack of C≡C stretching
vibration in the 2200cm-1 region.
Possible complications with this reaction could involve issues with steric
hindrance and competing side reactions. Firstly, compound 7contains two methyl
groups closely substituted to the site of the aryl halide participating in the crosscoupling reaction. These methyl groups could be sterically hindering the formation
of the PdII intermediate during oxidative addition, thus yielding a lower chance at
successfully being coupled to phenylacetylene. Secondly, although the CuI co27

catalyst is added to increase the reactivity of phenylacetylene, a Glaser coupling side
reaction could occur in the presence of air, which would produce the homocoupled
acetylene derivative.34
2.1.2 Analysis of Synthetic Scheme #2
Synthetic Scheme #2 (Figure 2.2) was designed to investigate whether a
Sonogashira cross-coupling reaction could occur using compound 3 as the aryl
halide source.

Figure 2.2: Synthetic Scheme #2
The conditions for the Sonogashira reaction were similar to those used
previously in synthetic Scheme #1, and ultimately the same problems arose. A
previous graduate student, Joseph Sbrocca, reported very low yields of product 9
(<10%), but despite multiple attempts the results could not be replicated.
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2.1.3 Analysis of Synthetic Scheme #3
Synthetic Scheme #3 (Figure 2.3) was designed as an alternative synthetic
route to avoid the previously proposed Sonogashira cross-coupling reactions.

Figure 2.3: Synthetic Scheme #3
Review of the literature showed how Studer et al. proposed a transition
metal-free Sonogashira-type coupling reaction using TEMPO as an oxidant. 35
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Following this method, the generation of Grignard compounds 12 and 13 was
completed through a halogen-metal exchange using iPrMgCl·LiCl. This method was
based on previous work done by Knochel et al. who discovered that the presence of
lithium salts with iPrMgCl could enhance the rate of halogen/Mg exchange at much
lower temperatures for the preparation of organomagnesium compounds.36 The
reactions to synthesize compounds 12 and 13 were completed at 0°C, in less than
two hours, and the products were used directly for the cross-coupling reaction with
TEMPO without further purification.
Compound 14 was successfully synthesized and data obtained from 1H NMR
spectroscopy was in accordance with values from literature.35 Compound 14 was
then subjected to a lithium-halogen exchange reaction to obtain compound 9.
Compound 9 then underwent a condensation reaction with compound 6 to
produce the desire neutral thread 8. Although initially low yielding, optimization of
reaction and workup conditions allowed for production of the neutral axle in much
higher yields.
Characterization of Compound 9 and Neutral Axle 8
Compound 9 and neutral axle 8 were both newly synthesized compounds
and therefore fully characterized.
Compound 9
1H

and 13C NMR spectroscopy data support the formation of compound 9, and

can be viewed in Chapter 3. IR spectroscopy was used to confirm the presence of the
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alkyne bond, and confirm the success of the Sonogashira-like coupling reaction with
TEMPO.
Table 1: IR Spectrum Analysis of Compound 9
Wavenumber (cm-)
Corresponding Vibrational Mode
2826.12-2786.55

Aromatic C-H Stretch

2729.06

Alkane C-H Stretch

2205.63

C≡C Stretch

1684.70

Aldehyde C=O Stretch

1597.26

Aromatic C=C Bend

Suitable crystals for single crystal X-ray crystallography were obtained by
slow evaporation of a solution of 9 in EtOH. A summary of the crystal data, solution,
and refinement parameters are presented in Table 2.

Figure 2.4: Ball-and-Stick representation of 9; black= carbon, white= hydrogen, red=
oxygen.
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Table 2: Crystal Data, Solution and Refinement Parameters for Compound 9
CCDC Number
***
V (Å3)
1305.73(15)
Formula

C17H14O

Z

4

Formula weight

234.28

ρ, g cm-3

1.192

Crystal system

Monoclinic

(Abs. Coef.) mm-1

0.073

Space group

P21/c

Reflections used

3977

T (K)

143.2

Parameters

165

a (Å)

7.8994(5)

Restraints

0

b (Å)

6.8690(5)

R1 [I > 2σ(I)][a]

0.0643

c (Å)

24.1401(16)

R1 (all data)

0.0752

α (°)

90

R2w [I > 2σ(I)][b]

0.1559

β (°)

94.552(15)

R2w (all data)

0.1655

σ (°)

90

GoF on F2

1.094

R1 = ||Fo| - |Fc||  |Fo|; R2w = [[w(Fo Fc ) ] / [w(Fo ) ]] , where w = q[ (Fo ) + (aP) + bP]
***Structure solution and refinment complete, CCDC number will be obtained upon deposition.
[a]

[b]

2-

2 2

2 2 1/2

2

2

2

-1

Neutral Axle 8
1H

and

13C

NMR spectroscopy data support the formation of neutral axle 8,

and can be viewed in Chapter 3. Assignment of the aromatic proton environments in
the neutral axle was completed with the aid of homonuclear Correlation
spectroscopy (COSY) and Nuclear Overhauser Effect spectroscopy (NOESY).
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Figure 2.5: Full NOESY spectrum of Neutral Axle 8
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Figure 2.6: Full COSY spectrum of Neutral Axle 8
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Figure 2.7: Proton environments of Neutral Axle 8

Figure 2.8: Cross-section of aromatic regions in COSY spectrum of 8
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IR spectroscopy was useful to confirm the presence of the N-H in the
benzimidazole, as well as the alkyne bond in the extended portion of the axle.
Table 3: IR Spectrum Analysis of Neutral Axle 8
Wavenumber (cm-)
Corresponding Vibrational Mode
3446.79

N-H Stretch

3049.57-2908.47

Aromatic C-H Stretch

2189.47

C≡C Stretch

1513.21

Aromatic C=C Bend

Suitable crystals for single crystal X-ray crystallography were obtained by
slow evaporation of a solution of 8 in a 1:1 mixture of EtOH:THF. A summary of the
crystal data, solution, and refinement parameters are presented in Table 4.

Figure 2.9: Ball-and-Stick representation of 8; black= carbon, white= hydrogen, blue=
nitrogen.
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Table 4: Crystal Data, Solution and Refinement Parameters for Compound 8
CCDC Number
***
V (Å3)
2510.7(3)
Formula

C35H26N2

Z

4

Formula weight

474.58

ρ, g cm-3

1.256

Crystal system

Monoclinic

(Abs. Coef.) mm-1

0.073

Space group

P21/c

Reflections used

4589

T (K)

173.15

Parameters

337

a (Å)

7.0644(5)

Restraints

0

b (Å)

14.9636(12)

R1 [I > 2σ(I)][a]

0.0756

c (Å)

23.7668(19)

R1 (all data)

0.0870

α (°)

90

R2w [I > 2σ(I)][b]

0.1951

β (°)

92.101(2)

R2w (all data)

0.2012

σ (°)

90

GoF on F2

1.107

R1 = ||Fo| - |Fc||  |Fo|; R2w = [[w(Fo Fc ) ] / [w(Fo ) ]] , where w = q[ (Fo ) + (aP) + bP]
***Structure solution and refinment complete, CCDC number will be obtained upon depostion.
[a]

[b]

2-

2 2

2 2 1/2

2

2

2

-1

37

2.1.4 Analysis of Synthetic Scheme #4
Due to the initially low yields from the condensation reaction between
compound 6 and compound 9, Synthetic Scheme #4 (Figure 2.10) was proposed as
an alternate synthetic scheme. Previous Loeb group members had successfully
synthesized T-shaped axles by completing the reductive elimination of sulfur and
subsequent condensation reactions prior to any Suzuki coupling reactions.18

Figure 2.10: Synthetic Scheme #4
This alternate synthetic pathway produced good yields for compound 16,
however isolating pure neutral axle 8 after the Suzuki coupling reaction with
phenylboronic acid was extremely difficult. Due to the large amount of phenyl rings
present in both compound 16 and the desired product, it was believed that π-π
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stacking interactions were greatly hindering the attempts of isolating the
unsubstituted axle from the di-, as well as mono-substituted products.
Ultimately, synthetic Scheme #3 (Figure 2.3) was chosen as the synthetic
route of choice to synthesize pure neutral axle 8.
2.1.5 Analysis of [2]Rotaxane Formation
Figure 2.11 outlines the synthetic route followed once pure neutral axle 8
was obtained.

Figure 2.11: Synthetic Scheme for [2]Rotaxane formation
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Neutral axle 8 was protonated through the addition of HBF4·Et2O to produce
[8-H][BF4], a protonated axle able to act as a recognition site for a ring-closing
metathesis reaction.

Figure 2.12: Synthetic Scheme for 24C6 Precrown formation
The [24]-crown-6-ether (24C6) precrown was synthesized through
tosylation of pentaethylene glycol, and subsequent alkylation with 4-pentene-1-ol to
produce the bis olefin. Using Grubb’s I catalyst (RuCl2(=CHPh)(PCy3)2), a ring-closing
metathesis reaction was conducted to clip the crown ether around the axle and
produce [2]rotaxane 11 as a mixture of both the E and Z isomers. This [2]rotaxane
was left as a mixture of isomers and not further reduced as to ensure the alkyne
bond in the extension of the axle was also not reduced.
Characterization of [2]rotaxane 11
Although the [2]rotaxane was synthesized as a mixture of both E and Z
isomers, small amounts of each isomer were able to be isolated and fully
characterized.
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1H

and 13C NMR spectroscopy data support the formation of [2]rotaxane 11,

and can be viewed in Chapter 3. Assignment of proton environments in each
[2]rotaxane was completed with the aid of COSY and NOESY spectroscopy
experiments.
Isomer 1

Figure 2.13: Full NOESY spectrum of [2]rotaxane 11 isomer 1
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Figure 2.14: Full COSY spectrum of [2]rotaxane 11 isomer 1
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Figure 2.15: Proton environments of [2]rotaxane 11 isomer 1

Figure 2.16: Cross-section of aromatic regions in COSY spectrum of isomer 1
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Figure 2.17: Cross-section of macrocyclic regions in COSY spectrum of isomer 1
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Isomer 2

Figure 2.18: Full NOESY spectrum of [2]rotaxane 11 isomer 2
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Figure 2.19: Full COSY spectrum of [2]rotaxane 11 isomer 2
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Figure 2.20: Proton environments of [2]rotaxane 11 isomer 2

Figure 2.21: Cross-section of aromatic regions in COSY spectrum of isomer 2
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Figure 2.22: Cross-section of macrocyclic regions in COSY spectrum of isomer 2

48

IR spectroscopy confirmed the presence of the N-H in the benzimidazole, the
alkyne bond in the extended portion of the axle, and the ether functional groups
present in the crown ether ring.
Table 5: IR Spectrum Analysis of [2]rotaxane 11 isomer 1
Wavenumber (cm-)
Corresponding Vibrational Mode
3261.83

N-H Stretch

2936.71-2951.19

Aromatic C-H Stretch

2864.01

Alkane C-H Stretch

2161.20

C≡C Stretch

1597.01

Aromatic C=C Bend

1091.50

Ether C-O Stretch

Table 6: IR Spectrum Analysis of [2]rotaxane 11 isomer 2
Wavenumber (cm-)
Corresponding Vibrational Mode
3249.12

N-H Stretch

2922.61-2907.57

Aromatic C-H Stretch

2864.01

Alkane C-H Stretch

2194.67

C≡C Stretch

1597.01

Aromatic C=C Bend

1091.06

Ether C-O Stretch
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Suitable crystals for single crystal X-ray crystallography were obtained by
slow evaporation of a solution of isomer 1 in EtOH. A summary of the crystal data,
solution, and refinement parameters are presented in Table 7. Suitable crystals of
isomer 2 were unable to be obtained after many trials.

Figure 2.23: Thermal ellipsoid representation of [2]rotaxane isomer 1; blue= axle,
red= wheel.
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Table 7: Crystal Data, Solution and Refinement Parameters for Compound 11
CCDC Number
***
V (Å3)
9300.4(4)
Formula

C53H60N2O6

Z

8

Formula weight

821.03

ρ, g cm-3

1.173

Crystal system

Monoclinic

(Abs. Coef.) mm-1

0.600

Space group

P21/c

Reflections used

15422

T (K)

173.2

Parameters

1286

a (Å)

12.0921(3)

Restraints

711

b (Å)

18.0370(4)

R1 [I > 2σ(I)][a]

0.1059

c (Å)

42.9385(10)

R1 (all data)

0.1518

α (°)

90

R2w [I > 2σ(I)][b]

0.2657

β (°)

96.7404(14)

R2w (all data)

0.3000

σ (°)

90

GoF on F2

1.060

R1 = ||Fo| - |Fc||  |Fo|; R2w = [[w(Fo Fc ) ] / [w(Fo ) ]] , where w = q[ (Fo ) + (aP) + bP]
***Structure solution and refinment complete, CCDC number will be obtained upon deposition.
[a]

[b]

2-

2 2

2 2 1/2

2

2

2

-1

Based on structure solution and observation of the alkene bond found in the
closed macrocyclic wheel, this isomer was determined to be the E isomer.
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2.2 Membrane Transport Studies
The chloride transport properties of neutral thread 8 and [2]rotaxane 11
were evaluated using EYPC LUVs and a chloride-selective electrode. For these
studies, the liposomes were encapsulated with 500 mM NaCl buffered to pH 7.2 with
5 mM phosphate buffer solution. They were then suspended at a lipid concentration
of 5 mM in 500 mM NaNO3 buffered to pH 7.2 with 5 mM phosphate buffer solution.
Experiments were initiated by the addition of a small amount of a DMSO solution of
the respective transporter with concentrations varied from 6.25 to 25 mol% relative
to the concentration of EYPC. The chloride efflux was monitored as a function of
time by the chloride-selective electrode. A detergent, Triton-X, was added at the end
of each experiment to lyse all liposomes, and the final electrode reading was used to
obtain the maximum of chloride efflux.
2.2.1 Monitoring Chloride Transport Properties of Neutral Axle
Using the kinetic results (Figure 2.24a), as well as a dose-response analysis
(Figure 2.24b), the effectiveness of the neutral axle in the chloride transport
process across the bilayer could be determined by its EC50 value. An EC50 value
provides the effective transporter concentration required to facilitate 50% chloride
efflux after a specific time period.37 For Cl-/NO3- antiport experiments, this time
period is 270 s. A dose-response analysis can also determine the Hill coefficient (n),
which can be used to describe the number of monomers found in the active
transport system required to perform the chloride transport process.37
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Figure 2.24: a) Efflux of Cl- in EYPC liposomes (5 mM) containing 6.25, 10, 12.5, 15, 20,
and 25 mol% (relative to phospholipid) of neutral axle 8. Intravesicular: 500 mM NaCl,
5 mM phosphate buffer (pH 7.2). Extravesicular: 500 mM NaNO3, 5 mM phosphate
buffer (pH 7.2). 8 was added at t = 0 s and Triton X was added at t = 540 s. Each curve
is the average of three independent measurements. b) Hill plot analysis obtained from
data shown in (a).
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The EC50 value for neutral axle 8 in a Cl-/NO3- antiport system was 13.6 ± 0.5 mol%
and the Hill coefficient was 4.7 ± 0.9.
2.2.2 Monitoring of Chloride Transport Properties of [2]Rotaxane
Using the kinetic results (Figure 2.25a), as well as a dose-response analysis
(Figure 2.25b), the effectiveness of the [2]rotaxane (mixture of both E and Z
isomers) in the chloride transport process across the bilayer could be determined by
its EC50 value.
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Figure 2.25: a) Efflux of Cl- in EYPC liposomes (5mM) containing 6.25, 10, 12.5, 15, 20,
and 25 mol% (relative to phospholipid) of [2]rotaxane 11. Intravesicular: 500 mM
NaCl, 5 mM phosphate buffer (pH 7.2). Extravesicular: 500 mM NaNO3, 5 mM
phosphate buffer (pH 7.2). 11 was added at t = 0 s and Triton X was added at t = 540 s.
Each curve is the average of three independent measurements. b) Hill plot analysis
obtained from data shown in (a).

55

The EC50 value for [2]rotaxane 11 in a Cl-/NO3- antiport system was 13.1 ± 0.7 mol%
and the Hill coefficient was 7.7 ± 2.9.
2.2.3 Evaluation of Transporter Effectiveness based on EC50 Values
Neutral axle 8 and [2]rotaxane 11 have EC50 values of 13.6 ± 0.5 mol% and
13.1 ± 0.7 mol% respectively, almost twenty times higher than the EC50 value
reported for 2,4,7-triphenylbenzimidazole (0.67 ± 0.1 mol%).30 Therefore, these
transporters are extremely inefficient in chloride transport across a lipid membrane,
especially when compared to the efficiency of other synthetic transporters reported
in the literature.37
2.2.4 Comparison of Neutral Axle 8 and 2,4,7-triphenylbenzimidazole
In order to have a better understanding of the differences in chloride
transport efficiencies between the neutral axle 8 and 2,4,7-triphenylbenzimidazole,
self-assembly of each transporter in the solid state was compared.
Figure 2.26 shows the crystal organization of 8 in the solid state with the
formation of planar sheets driven by π-π stacking interactions. These sheets create a
hydrophobic area in between layers, allowing for the possibility of anion-π
interactions between chloride anions and transporter. The presence of the N-H on
the benzimidazole unit also provides the possibility of hydrogen bonding
interactions with chloride anions.
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Figure 2.26: Crystal organization showing formation of planar sheets between neutral
axle 8. a) Ball-and-stick representation along side-view, and b) Wire representation of
top-view; Blue and red are alternating sheets. Hydrogens omitted for clarity.
The formation of sheets is driven by edge-to-face π-π interactions measuring
2.9 Å between molecules in different layers. The width of these sheets was measured
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to be approximately 35 Å, each sheet consisting of two molecules. This is slightly
higher than the expected thickness of the hydrophobic portion of a bilayer. If the
active transport system required the anion to pass in between two layers, this
system would require two monomers to assemble into a sheet and interact with
another sheet consisting of two monomers, thereby having four monomers
assembled into the active system. The Hill number for neutral axle 8 was found to be
4.7 ± 0.9, supporting the idea of sheet formation. However, molecular modelling
would be necessary to confirm the preservation of planar sheet structure in the
presence of phospholipids.
Schmitzer et al. previously showed how 2,4,7-triphenylbenzimidazole selfassembles into helical rods (Figure 2.27), driven by the formation of hydrogen
bonds between individual molecules, and stabilized by π-π interactions.30
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Figure 2.27: Crystal organization showing formation of helical rods of 2,4,7triphenylbenzimidazole driven by hydrogen bond formation (shown in black). Balland-stick representation along a) side-view, and b) top-view; red and blue are
alternating subunits.
The differences between the self-assembly of the two can be attributed to the
large difference in size. Neutral axle 8 is a much larger molecule, and therefore
cannot compact as closely as 2,4,7-triphenylbenzimidazole. The methyl groups
prevent the formation of a helical structure through steric hindrance, and therefore
prevent hydrogen bonding interactions between monomers. As well, the addition of
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another phenyl ring allows π-π stacking interactions to be the driving force for selfassembly.
In order to for a molecule to be an efficient synthetic transporter, it must be
water-soluble for delivery to the liposome, but also sufficiently lipophilic for
insertion into the phospholipid membrane. The addition of another phenyl ring does
increases

the

lipophilicity

of

the

neutral

axle

8

compared

to

2,4,7-

triphenylbenzimidazole, however this also decreases its solubility in water. At high
concentrations, small amounts of white precipitate were observed upon addition of
8. This suggests that the molecule was not fully delivered to the membrane for
insertion, and therefore would have low transport efficiency, as seen with a high
EC50 value (13.6 ± 0.5 mol%).
2.2.5 Comparison of [2]rotaxane 11 and 2,4,7-triphenylbenzimidazole
The crystal organization of [2]rotaxane 11 is remarkably different from the
neutral axle 8 and 2,4,7-triphenylbenzimidazole. As shown in Figure 2.28, adding a
ring to the axle disrupts the ability of the molecule to utilize π-π stacking
interactions, prevents tight packing, and hinders the formation of planar sheets. The
ring also interacts with the N-H on the benzimidazole, preventing any
intermolecular hydrogen bonding, and hindering the formation of helical rods.
Instead the molecules align offset of one another due to spatial constraints with the
presence of the ring.
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Figure 2.28: Crystal organization of [2]rotaxane 11. Ball-and-stick representation
along a) a-axis, b) b-axis, c) c-axis; red and blue are alternating subunits. Hydrogens
omitted for clarity.
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During chloride transport studies with 11, it was observed that addition of
the transporter produced a white precipitate in solution, suggesting that the
[2]rotaxane was not inserted into the membrane for proper facilitation of chloride
transport. This may be due to the interaction of the ring with the N-H on the
benzimidazole, increasing the lipophilicity of the molecule, but once again, greatly
hindering the transporters solubility in water. The high EC50 value (13.1 ± 0.7 mol%)
and the large Hill coefficient (7.7 ± 2.9) could also be attributed to low efficiency of
the transporter if it was not properly inserted into the membrane.
To determine whether the minimal voltage change detected by the ISE was
due to transport by molecule 11 or solvent effects of DMSO, 15 μL of pure DMSO was
added as a blank and chloride transport was monitored. DMSO is a small
amphiphilic molecule that has been shown to insert itself into lipid membranes and
enhance membrane permeability by producing transient defects (pores) to facilitate
ionic leakage.38 As seen in Figure 2.25a, minimal transport was reported and the
percentage of chloride efflux was similar to the value obtained for 25 mol% of
transporter. Therefore, the chloride efflux observed was most likely due to the
solvent effects of DMSO, and supports the idea of minimal insertion of the
[2]rotaxane 11 into the lipid membrane.
2.2.6 The Importance of N-H for Ion Transport
The results obtained from these studies provide important information about
the mechanism of transport using synthetic molecules with benzimidazole cores as
transporters. As seen with [2]rotaxane 11, having a component such as a crown
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ether ring associate with the axle through the N-H of the benzimidazole inhibits the
formation of hydrogen bonds with the anion, and therefore produces total inhibition
of transport. Although some anion-π interactions are still available, the observation
of inhibited transport supports the idea that hydrogen bond formation with anions
is a strong driving force for transport.
Neutral axle 8 was later protonated with HCl to produce [8-H][Cl-] to study
the interaction of chloride anions with the axle. Suitable crystals for single crystal Xray crystallography were obtained by slow diffusion of isopropyl ether vapour into a
solution of [8-H][Cl-] in THF. A summary of the crystal data, solution, and refinement
parameters are presented in Table 8.

Figure 2.29: Thermal ellipsoid representation of X-ray crystal structure of [8-H][Cl-];
black= carbon, blue= nitrogen, white= hydrogen, green= chlorine. Solvent omitted for
clarity.
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Table 8: Crystal Data, Solution and Refinement Parameters for [8-H][Cl-]
CCDC Number
***
V (Å3)
6169.9(3)
Formula

C35H27ClN2 ·

Z

12

0.5(C6H14O)
Formula weight

562.16

ρ, g cm-3

1.2103

Crystal system

Monoclinic

(Abs. Coef.) mm-1

1.320

Space group

C2/c

Reflections used

4449

T (K)

170.0

Parameters

378

a (Å)

27.4250(8)

Restraints

0

b (Å)

21.0755(6)

R1 [I > 2σ(I)][a]

0.0391

c (Å)

11.1967(3)

R1 (all data)

0.0543

α (°)

90

R2w [I > 2σ(I)][b]

0.0912

β (°)

107.5660(16)

R2w (all data)

0.0999

σ (°)

90

GoF on F2

1.058

R1 = ||Fo| - |Fc||  |Fo|; R2w = [[w(Fo Fc ) ] / [w(Fo ) ]] , where w = q[ (Fo ) + (aP) + bP]
***Structure solution and refinment complete, CCDC number will be obtained upon desposition.
[a]

[b]
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Figure 2.30 displays how chloride anions interact with multiple subunits
between the planar sheets formed by the axle through hydrogen bonding. Although
anion-π interactions are still present, without the ability to hydrogen bond with the
axle, chloride anions do not seem to be transported as efficiently across a
membrane. Again, molecular modelling would be necessary to confirm the
preservation of planar sheet structure in a membrane to support the idea of chloride
interaction via hydrogen bonding between sheets formed by neutral axle 8.
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Figure 2.30: Ball-and-stick representation of chloride anion interaction between
planar sheets; blue and red are alternating sheets.
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2.3 Summary and Future Work
A new T-shaped axle, 8, and related [2]rotaxane, 11, were successfully
synthesized and characterized. Multiple synthetic routes were designed and
attempted due to problems that arose with extending the T-shaped axle from the
original 2,4,7-triphenylbenzimidazole axle. Throughout the synthetic process it was
established that a Sonogashira cross-coupling reaction was not optimal to introduce
an alkyne bond due to the steric hindrance provided by the methyl groups found on
the axle. Instead, a transition metal-free Sonogashira-like cross coupling reaction
using organomagnesium compounds and TEMPO as an oxidant was completed to
produce the extension of the T-shaped axle.
Chloride transport studies were completed using 8 and 11 as synthetic
transporters. EC50 values were found to be 13.6 ± 0.5 mol% and 13.1 ± 0.7 mol%
respectively, almost twenty times higher than the EC50 value reported for 2,4,7triphenylbenzimidazole (0.67 ± 0.1 mol%). Therefore, 8 and 11 were not efficient
chloride transporters. The importance of having the N-H of the benzimidazole
present should be further investigated as future work using molecular modelling.
Expanding on the idea of using [2]rotaxanes as synthetic transporters, future
work could also include investigating bis(benzimidazolium) axles. This type of axle
provides a free N-H site available for hydrogen bonding with anions, while also
incorporating a crown ether wheel to form a [2]rotaxane. Although the H-shaped
axle shown below may present solubility issues in polar environments, the
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bis(benzimidazolium) axle could be functionalized to assist with water-solubility
and transporter delivery to cell membranes.

Figure 2.31: H-Shaped bis(benzimidazolium) axle and related [2]rotaxane.
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CHAPTER 3 – Experimental
3.1 General Comments
All reagents and starting materials were purchased from Aldrich and used as
received. Deuterated solvents were obtained from Aldrich or Cambridge Isotope
Laboratories and used as received. THF, DCM, and MeCN were dried upon 3Å
molecular sieves. Thin layer chromatography (TLC) was performed using Teledyne
Silica Gel 60 F253 plates and viewed under UV light. Column chromatography was
performed using Silicycle Ultra-Pure Silica Gel (230-400 mesh). 1H,

13C,

and all 2-D

NMR spectra were obtained on a Brüker Advance 500 instrument, with working
frequencies of 500.1 MHz for 1H nuclei and 125.7 MHz for

13C.

Chemical shifts are

quoted in ppm relative to tetramethylsilane using the residual solvent peak as a
reference standard. High resolution mass spectrometry (HR-MS) experiments were
performed on a Waters XEVO G2-XS TOF instrument and completed in ESI positive
resolution mode. All single crystal X-ray data was collected on a Brüker D8
diffractometer with a Photon 100 CCD detector operated at 50 kV and 30 mA with a
MoKα radiation. All IR spectra were collected using a Brüker-Equinox Infrared
microscopy and mapping instrument. Melting points were obtained using an
OptiMelt Automated Melting Point System. Liposomes were prepared from L-α
Phosphatidylcholine

purchased

from

Avanti

Polar

Lipids.

Size-exclusion

chromatography was performed using Sephadex G-25.
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3.2 Synthesis of 1

Figure 3.1: Compound 1
A solution of 3,5-dimethylaniline (10.0 g, 0.0825 mol) in 83 mL of dry MeCN was
placed in a 250 mL Schlenk flask at 0°C under an inert nitrogen atmosphere. A
solution of NBS (14.7 g, 0.0825 mol) in dry MeCN was added dropwise via an
addition funnel over 1 h. The reaction was allowed to come to room temperature
and stirred for an additional 72 h. The reaction was quenched via the addition of DI
H2O. MeCN was removed under reduced pressure, followed by extraction with
EtOAc (3 x 150 mL). The remaining organic phase was isolated, dried over MgSO4,
filtered and concentrated under reduced pressure. The resulting crude orange solid
was recrystallized from hexanes. The product was isolated as a light brown solid;
isolated yield: (13.21 g, 80%). 1H NMR (500 MHz, Chloroform-d): δ= 6.47 b (s, 2H),
3.56 NH (br s, 2H), 2.35 a (s, 6H). Values obtained are in accordance with
literature.39
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3.3 Synthesis of 2

Figure 3.2: Compound 2
1 (5.00 g, 0.0250 mol) was suspended in 100 mL of DI H2O. The mixture was kept at
0°C and concentrated H2SO4 (7.14 mL, 5 eq, 0.125 mol) was added dropwise. The
mixture was stirred for 0.5 h, after which 67 mL of acetone was added and the
contents stirred for an additional 0.5 h. A solution of NaNO2 (5.17 g, 3 eq, 0.0750
mol) in 80.5 mL DI H2O was added dropwise and the resulting mixture was stirred
for 1h. While maintaining the temperature of the reaction at 0°C, a solution of KI
(20.7 g, 5 eq, 0.125 mol) in 82.5 mL of DI H2O was added dropwise. The solution
turned brown and was allowed to stir while warming to room temperature
overnight. Following completion, an extraction with EtOAc (3 x 100 mL) was
performed. The organic phase was collected and washed once with 165 mL of a 1M
HCl solution, and twice with 100 mL of a 20 wt% NaHSO3 solution. The remaining
organic phase was then collected, dried over Na2SO4, filtered and concentrated
under reduced pressure. The product was purified and isolated by column
chromatography (100% hexane) Rf = 0.71. The product was isolated as a colourless
oil; isolated yield: 6.90 g (89%). 1H NMR (500 MHz, Chloroform-d) δ= 7.40 b (s, 2H),
2.36 a

(s,

6H).

Values

obtained are in

accordance

with literature

40
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3.4 Synthesis of 3

Figure 3.3: Compound 3
2 (5.00 g, 0.0161 mol) was dissolved in 200 mL of dry THF in a 250 mL Schlenk flask
under an inert nitrogen atmosphere. The reaction was cooled to -78°C, followed by
dropwise addition of nBuLi (10.0 mL of a 1.6M solution in hexanes, 1 eq, 0.0161
mol). While maintaining the temperature at -78°C, the reaction mixture was stirred
for 1 h, after which DMF (3.70 mL, 3.1 eq, 0.0499 mol) was added dropwise and the
reaction warmed to room temperature overnight. The reaction was then acidified
with 100 mL of a 5 wt% HCl solution, followed by an extraction with Et2O (3 x 100
mL). The organic phase was collected, dried over MgSO4, filtered and concentrated
under reduced pressure. The crude product was purified and isolated by column
chromatography (hexane/EtOAc, 10:1 v/v) Rf = 0.38. The product was isolated as a
white crystalline solid; isolated yield: 2.00 g (58%). 1H NMR (500 MHz, Chloroformd) δ= 9.92 c (s, 1H), 7.56 b (s, 2H), 2.49 a (s, 6H). Values obtained are in accordance
with literature.41
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3.5 Synthesis of 4

Figure 3.4: Compound 4
2,1,3-benzothiadiazole (8.00 g, 0.0587 mol) was dissolved in 150 ml of HBr in a 500
mL two-necked round bottom flask. A solution of Br2 (9.06 mL, 3 eq, 0.176 mol)
dissolved in 100 mL of HBr was added dropwise very slowly, and the resulting
mixture was stirred at reflux for 24 h. The mixture was cooled to room temperature,
followed by the addition of a saturated solution of NaHSO3 to consume excess Br2.
The solution was then filtered, washed with cold EtOH and the solvent was removed
under reduced pressure. The product was isolated as a red solid; isolated yield: 14.4
g (84%). 1H NMR (500 MHz, Chloroform-d) δ= 7.74 a (s, 2H). Values obtained were
in accordance with literature.42
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3.6 Synthesis of 5

Figure 3.5: Compound 5
4 (4.20 g, 0.0143 mol), phenylboronic acid (5.23 g, 3 eq, 0.0429 mol), palladium
tetrakis(triphenylphosphine) (0.825 g, 0.05 eq, 0.000714 mol) and cesium
carbonate (14.0 g, 3 eq, 0.0429 mol) were added to a 500 mL Schlenk flask under an
inert nitrogen atmosphere. A 250 mL mixture of degasses and dried DMF/toluene
(1:1) was added to the reaction flask and the resulting mixture was heated to 110°C
and stirred for 24 h. The mixture was cooled to room temperature, filtered and the
solvent removed under reduced pressure. The resulting crude brown solid was
recrystallized from EtOH. The product was isolated as a bright, yellow crystalline
solid; isolated yield: 3.28 g (80%). 1H NMR (500 MHz, Chloroform-d) δ= 8.02 – 7.91
b (m, 4H), 7.80 a (s, 2H), 7.62 – 7.41 c,d (m, 6H). Values obtained were in accordance
with literature.42
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3.7 Synthesis of 6

Figure 3.6: Compound 6
5 (3.00 g, 0.0104 mol) was dissolved in a 330 mL mixture of EtOH/THF (3:1 v/v)
and NaBH4 (2.75 g, 7 eq, 0.0728 mol) was added slowly. CoCl2·6H2O (0.0495 g, 2
mol%, 0.000208 mol) was then added and the mixture was stirred at reflux for 2 h
while monitored by TLC (in 100% DCM). Over the course of 5 h, an additional 7 eq of
NaBH4 and 3 mol% CoCl·6H2O were added in increments while the reaction
continued to stir at reflux and be monitored by TLC. Upon completion, the reaction
was cooled to room temperature, filtered and the solvent removed under reduced
pressure. The crude product was dissolved in 400 mL of Et2O/H2O (1:1 v/v),
followed by an extraction of the aqueous phase with Et2O (3 x 150 mL). The organic
phase was collected, dried over MgSO4, filtered and solvent removed under reduced
pressure. The product was isolated as a white crystalline solid and immediately
stored under an inert atmosphere of nitrogen; isolated yield: 2.44 g (90%). 1H NMR
(500 MHz, Chloroform-d) δ= 7.52 – 7.35 b,c,d (m, 10H), 6.80 a (s, 2H), 2.91 NH (br s,
4H). Values obtained are in accordance with literature.43
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3.8 Synthesis of 7

Figure 3.7: Compound 7
3 (0.385 g, 0.00181 mol) was dissolved in 188 mL of CHCl3, followed by the addition
of ZrCl4 (0.0421 g, 10 mol%, 0.000181 mol) and the resulting mixture was stirred for
10 minutes. 6 (0.470 g, 0.00181 mol) was then added and the reaction was stirred
for 24 h at room temperature. Upon completion, the solvent was removed under
reduced pressure. The resulting crude orange solid was washed with hot EtOH. The
product was isolated as a pale orange solid; isolated yield: 1.08 g (60%). 1H NMR
(500 MHz, Chloroform-d) δ= 7.89 b (d, 4H), 7.81 e (s, 2H), 7.60 – 7.53 c (m, 4H), 7.48
a (s, 2H), 7.46 – 7.42 d (m, 2H), 2.44 f (s, 6H).
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3.9 Synthesis of 8 via Synthetic Scheme 1

Figure 3.8: Neutral Axle 8
7 (0.200 g, 0.000441 mol), phenylacetylene (0.0581 mL, 1.2 eq, 0.000529 mol), CuI
(0.00840 g, 10mol%, 0.0000441 mol) PdCl2(PPh3)2 (0.0155 g, 5 mol%, 0.0000221
mol) and PPh3 (0.0321 g, 0.27 eq, 0.000119 mol) were added to a 250 mL Schlenk
flask under an inert nitrogen atmosphere. A 125 mL mixture of degassed NEt3/THF
(3:2) was added to the reaction flask and reaction was stirred at reflux overnight.
Upon completion, the reaction was cooled to room temperature, filtered and the
solvent removed under reduced pressure. The crude product was attempted to be
isolated by column chromatography (hexanes/DCM, 10:1 v/v). Despite multiple
attempts at purification, the product was never isolated via this synthetic route.
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3.10 Synthesis of 9 via Synthetic Scheme 2

Figure 3.9: Compound 9
3 (0.600 g, 0.00282 mol), phenylacetylene (0.371 mL, 1.2 eq, 0.00338 mol), CuI
(0.0536 g, 10 mol%, 0.000282 mol), PdCl2(PPh3)2 (0.0988 g, 5mol%, 0.000141 mol)
and PPh3 (0.199 g, 0.27 eq, 0.000760 mol) were added to a 250 mL Schlenk flask
under an inert nitrogen atmosphere. A 75 mL mixture of degassed NEt3/THF (3:2)
was added to the reaction flask and reaction was stirred at reflux overnight. Upon
completion, the reaction was cooled to room temperature, filtered and the solvent
removed under reduced pressure. The crude product was attempted to be isolated
by column chromatography (hexanes/DCM (3:1  1:1 v/v). Despite multiple
attempts at purification, the product was never isolated via this synthetic route.
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3.11 Synthesis of 1b

Figure 3.10: Compound 1b
A solution of 2,6-dimethylaniline (5.00 g, 0.0413 mol) in 41 mL of dry MeCN was
placed in a 250 mL Schlenk flask at 0°C under an inert nitrogen atmosphere. A
solution of NBS (7.34 g, 0.0413 mol) in MeCN was added dropwise via an addition
funnel over 1 h. The reaction was allowed to come to room temperature and stirred
for an additional 72 h. The reaction was then quenched via the addition of DI H 2O.
MeCN was removed under reduced pressure, followed by extraction with EtOAc (3 x
150 mL). The remaining organic phase was isolated, dried over MgSO4, filtered and
concentrated under reduced pressure. The resulting crude purple solid was
recrystallized from hexanes. The product was isolated as a light brown solid;
isolated yield: 4.90 g (59%). 1H NMR (500 MHz, Chloroform-d) δ= 7.09 b (s, 2H),
3.61 NH (br s, 2H), 2.18 a (s, 6H). Values obtained are in accordance with
literature.39
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3.12 Synthesis of 2b

Figure 3.11: Compound 2b
1b (5.00 g, 0.0250 mol) was suspended in 100 mL of DI H2O. The mixture was kept
at 0°C and concentrated H2SO4 (7.14 mL, 5 eq, 0.125 mol) was added dropwise. The
mixture was stirred for 0.5 h, after which 67 mL of acetone was added and the
contents stirred for an additional 0.5 h. A solution of NaNO2 (5.17 g, 3 eq, 0.0750
mol) in 80.5 mL DI H2O was added dropwise and the resulting mixture was stirred
for 1 h. While maintaining the temperature of the reaction at 0°C, a solution of KI
(20.7 g, 5 eq, 0.125 mol) in 82.5 mL of DI H 2O was added dropwise. The solution
turned brown and was allowed to stir while warming to room temperature
overnight. Following completion, an extraction with EtOAc (3 x 100 mL) was
performed. The organic phase was collected and washed once with 165 mL of a 1M
HCl solution and twice with 100 mL of a 20 wt% NaHSO3 solution. The remaining
organic phase was then collected, dried over Na2SO4, filtered and concentrated
under reduced pressure. The crude product was purified and isolated by column
chromatography (100% hexanes) Rf= 0.56. The product was isolated as a white
crystalline solid; isolated yield: 6.25 g (80%). 1H NMR (500 MHz, Chloroform-d) δ=
7.20 b (s, 2H), 2.44 a (s, 6H). Values obtained are in accordance with literature.40
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3.13 Synthesis of 12

Figure 3.12: Compound 12
Phenylacetylene (0.706 mL, 0.00643 mol) was dissolved 16 mL of dry THF at 0°C
under an inert nitrogen atmosphere. i-PrMgCl•LiCl in THF (1.3 M, 5.44 mL, 1.1 eq,
0.00707 mol) was added dropwise while maintaining the temperature at 0°C, and
the resulting mixture was then stirred at room temperature for 1 h. This alkynyl
Grignard reagent was used directly for the cross coupling reaction.
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3.14 Synthesis of 13

Figure 3.13: Compound 13
2b (5.00 g, 2.5 eq, 0.0161 mol) was dissolved 25 mL of dry THF at 0°C under an inert
nitrogen atmosphere. i-PrMgCl•LiCl in THF (1.3 M, 13.6 mL, 1.1 eq, 0.0177 mol) was
added dropwise while maintaining the temperature at 0°C, and the resulting mixture
was then stirred at room temperature for 1.7 h. This aryl Grignard reagent was used
directly for the cross coupling reaction.
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3.15 Synthesis of 14

Figure 3.14: Compound 14
The solution containing 13 was transferred to the flask containing a solution of 12
via syringe the resulting mixture was stirred for 5 to 10 min at room temperature.
TEMPO (3.87 g, 3.85 eq, 0.0248 mol) was added and the mixture was stirred at
reflux for 2.5 h. The reaction mixture was then treated with hexanes (35 mL) and
saturated aqueous NH4Cl solution (65 mL). The aqueous layer was extracted with
hexanes (2 x 60 mL). The remaining organic phase was then collected, washed with
brine, dried over MgSO4, filtered and concentrated under reduced pressure. The
product was purified and isolated by column chromatography (100% hexane) Rf =
0.34. The product was isolated as a white crystalline solid; isolated yield: 1.68 g
(91%). 1H NMR (500 MHz, Chloroform-d) δ 7.56 – 7.51 c (m, 2H), 7.39 – 7.32 a,b (m,
3H), 7.24 e (s, 2H), 2.48 d (s, 6H). Values obtained are in accordance with
literature.35
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3.16 Synthesis of 9 via Synthetic Scheme 3

Figure 3.15: Compound 9
14 (2.75 g, 0.00964 mol) was dissolved in 150 mL of dry THF in a 500 mL Schlenk
flask under an inert nitrogen atmosphere. The reaction was cooled to -78°C,
followed by dropwise addition of nBuLi (6.63 mL of a 1.6M solution in hexanes, 1.1
eq, 0.0106 mol). While maintaining the temperature at -78°C, the reaction mixture
was stirred for 1 h, after which DMF (2.44 mL, 3.4 eq, 0.0328 mol) was added
dropwise and the reaction warmed to room temperature overnight. The reaction
was then acidified with 35 mL of a 5 wt% HCl solution, followed by an extraction
with Et2O (3 x 60 mL). The organic phase was collected, dried over MgSO4, filtered
and concentrated under reduced pressure. The crude product was purified and
isolated by column chromatography (hexane/CHCl3, 10:1 v/v) Rf = 0.23. The product
was isolated as a white crystalline solid; isolated yield: 1.87 g (83%). M.P. 78°C. HRMS: Calculated for [M+H]+ [C17H15O]+ m/z = 235.1123; found m/z = 235.1121.
1H

NMR (500 MHz, Chloroform-d) δ= 9.95 a (s, 1H), 7.58 b (s, 2H), 7.57 – 7.55 d (m,

2H), 7.41 – 7.37 e,f (m, 3H), 2.58 c (s, 6H).
13C

NMR (126 MHz, CDCl3) δ= 192.06, 141.04, 135.00, 131.63, 129.46, 128.90,

128.56, 127.85, 123.06, 101.80, 86.56, 21.12.
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3.17 Synthesis of 8 via Synthetic Scheme 3

Figure 3.16: Neutral Axle 8
6 (0.389 g, 0.00149 mol) and 9 (0.350 g, 1 eq, 0.00149 mol) were dissolved in 15 mL
of CHCl3. ZrCl4 (0.0418 g, 10 mol%, 0.000149 mol) was added and the reaction was
stirred for 24 h at room temperature. Upon completion, NEt3 (0.5 mL) was added to
neutralize any protonated compound and the solvent was removed under reduced
pressure. The resulting crude orange solid was recrystallized from EtOH. The
product was isolated as an off white solid; isolated yield: 0.388 g (54%). M.P. 233°C.
HR-MS: Calculated for [M+H]+ [C35H26N2]+ m/z = 475.2174; found m/z = 475.2174.
1H

NMR (500 MHz, DMSO-d6) δ= 12.67 NH (s, 1H), 8.17 b’ (d, J = 7.2 Hz, 2H), 8.12 e

(s, 2H), 7.74 d (d, J = 7.2 Hz, 2H), 7.60 – 7.58 g (m, 2H), 7.58 – 7.54 c’ (m, 2H), 7.53 a’
(d, J = 3.6 Hz, 1H), 7.51 – 7.48 c (m, 2H), 7.48 – 7.43 h,i (m, 3H), 7.41 d,d’ (t, J = 7.4
Hz, 2H), 7.32 a (d, J = 7.7 Hz, 1H), 2.56 f (s, 6H).
13C

NMR (126 MHz, DMSO) δ= 151.95, 142.03, 139.94, 138.20, 137.94, 133.53,

131.25, 129.87, 129.33, 128.92, 128.83, 128.76, 128.52, 128.33, 127.56, 127.13,
125.62, 125.29, 123.47, 122.54, 121.36, 99.30, 86.75, 45.55, 20.79, 8.60.
84

3.18 Synthesis of 15

Figure 3.17: Compound 15
4 (1.00 g, 0.00340 mol) was dissolved in 50 mL of absolute EtOH in a 250 mL
Schlenk flask under an inert nitrogen atmosphere at 0°C. NaBH4 (1.29 g, 10 eq,
0.0340 mol) was then added slowly over 1 h. The reaction was allowed to stir at 0°C
for 1 h and warmed to room temperature overnight. Upon completion, H 2O (10 mL)
was added and EtOH removed under reduced pressure followed by an extraction
with DCM (3 x 20 mL). The organic phase was collected, dried over MgSO4, filtered
and solvent removed under reduced pressure. The product was isolated as a light
yellow crystalline solid; isolated yield: 0.83 g (92%). 1H NMR (500 MHz, Chloroformd) δ = 7.74 ppm a (s, 2H). Values obtained are in accordance with literature.43
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3.19 Synthesis of 16

Figure 3.18: Compound 16
15 (0.750 g, 0.00282 mol) and 9 (0.661 g, 1 eq, 0.00282 mol) were dissolved in 60
mL of CHCl3. ZrCl4 (0.0657 g, 10 mol%, 0.000282 mol) was added and the reaction
was stirred for 24 h at room temperature. Upon completion, NEt3 (0.5 mL) was
added to neutralize any protonated compound and the solvent was removed under
reduced pressure. The resulting crude orange solid was washed with MeOH. The
product was isolated as a pale yellow solid; isolated yield: 0.979 g (72%). 1H NMR
(500 MHz, Methylene Chloride-d2) δ 9.70 NH (br s, 1H), 7.84 b (s, 2H), 7.62 – 7.55 d
(m, 2H), 7.43 – 7.38 e,f (m, 3H), 7.33 a (s, 2H), 2.62 c (s, 6H).
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3.20 Synthesis of Precrown, Pentaethyleneglycol-dipent-4-enyl ether

Fugure 3.19: Pentaethyleneglycol-dipent-4-enyl ether
Ditosylated pentaethylene glycol was prepared according to literature procedure. 44
NaH in 60% mineral oil (15.7 g, 0.393 mol) was slowly added to 200 mL of dry THF
in a 500 mL Schlenk flask under an inert nitrogen atmosphere at 0°C. 4-pentene-1-ol
(33.8 g, 1 eq, 0.393 mol) was dissolved in 40 mL of THF, added to the reaction
mixture dropwise and allowed to stir for 1 h. Ditosylated pentaethylene glycol
(21.45 g, 0.1 eq, 0.0393 mol) was dissolved in 125 ml of THF and added slowly to
the reaction mixture via a syringe. The reaction mixture was allowed to warm to
room temperature and stirred for 48 h after which the reaction was quenched with
500 mL of water. The non-aqueous solvent was removed under reduced pressure
and the aqueous phase was extracted with CHCl3 (3 x 250 mL). The organic phase
was collected, washed with 1 M HCl (2 x 100 mL), dried over MgSO4, and the solvent
removed under reduced pressure. The crude product was purified and isolated by
column (EtOAc/Hexanes, 3:2 v/v,) Rf= 0.4. The product was isolated as a colourless
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oil; isolated yield: 6.45 g (64%).1H NMR (500 MHz, Chloroform-d) δ= 5.81 c (br m,
2H), 5.02 b (m, 2H), 4.96 a (m, 2H), 3.65 h (s, 16H), 3.56 g (br m, 4H), 3.46 f (t, 4H),
2.11 d (br m, 4H), 1.68 e (br m, 4H). Values are in accordance with literature.45
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3.21 Synthesis of [8-H][BF4-]

Figure 3.20: Compound [8-H][BF4]8 (0.263 g, 0.000554 mol) was suspended in MeCN (5 mL) and HBF4·Et2O (75.4 μL, 1
eq, 0.000554 mol) was added dropwise. The reaction was allowed to stir for 1 h. The
solvent was removed under reduced pressure and the resulting solid was washed
with Et2O (2 x 20 mL) to remove excess acid, filtered and collected. The product was
isolated as a white solid; isolated yield: 0.286 g (92%). 1H NMR (500 MHz,
Acetonitrile-d3) δ= 12.26 NH (s, 2H), 7.82 e (s, 2H), 7.76 – 7.73 b (m, 4H), 7.71 a (s,
2H), 7.67 – 7.63 c,d (m, 6H), 7.61 – 7.57 g (m, 2H), 7.48 – 7.44 h,i (m, 3H), 2.63 f (s,
6H).
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3.22 Synthesis of [2]rotaxane 11

Figure 3.21: [2]Rotaxane 11, E/Z isomers
[8-H][BF4-] (0.230 g, 0.000421 mol) and pentaethyleneglycol-dipent-4-enyl ether
(0.237 g, 1.5 eq, 0.000632 mol) were added in a 100 mL Schlenk flask under an inert
nitrogen atmosphere. Dry DCM (30 mL) was added to the flask and reaction stirred
for 10 min. Grubbs I catalyst [[RuCl2(=CHPh)(PCy3)2] (0.0345 g, 10 mol%,
0.0000421 mol) was dissolved in DCM (1 mL) and added to the reaction. The
reaction was stirred at reflux for 18 h after which additional catalyst (0.0173 g, 5
mol%, 0.0000211 mol) was added. The reaction was monitored by 1H NMR and 5
mol% of catalyst was added in 24 h intervals until a total of 25 mol% catalyst was
added. Upon completion, the solvent was removed under reduced pressure, and the
crude solid was washed and sonicated in Et2O. The solid was re-dissolved in DCM
and washed with saturated solution of NaHCO3. The crude product was purified and
isolated by column (Hexanes/ EtOAc, 7:1  2:1 v/v) Rf isomer 1= 0.5, Rf isomer 2 = 0.22.
The product obtained from the column was further purified via recrystallization
from EtOH. Isomer 1 (E) was isolated as a white crystalline solid; isolated yield:
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0.0310 g. Isomer 2 (Z) was isolated as a grey crystalline solid; isolated yield
0.0300g. Combined yield: 0.0610 g (18%). M.P. 186.8°C.
HR-MS: Calculated for [M+H]+ [C53H61N2O6]+ m/z = 821.4529; found m/z =
821.4536.
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3.23 Synthesis of [8-H][Cl-]

Figure 3.22: Compound [8-H][Cl-]
8 (0.030 g, 0.0000632 mol) was dissolved in DCM (5 mL) and HCl·Et2O (excess) was
added dropwise until a white precipitate appeared. The resulting solid was filtered
and collected. The product was isolated as a white solid; isolated yield: 0.0290 g
(92%). 1H NMR (500 MHz, DMSO-d6) δ= 8.10 e (s, 2H), 7.90 b (d, J = 7.5 Hz, 4H), 7.62
a (d, J = 3.4 Hz, 2H), 7.61 – 7.56 g,h,i (m, 5H), 7.49 d (t, J = 3.8 Hz, 2H), 7.46 c (dd, J =
5.2, 1.9 Hz, 2H), 2.57 f (s, 6H).
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3.24 Preparation of EYPC large unilamellar vesicles (LUVs)
A phospholipid film was formed by evaporating a 1 mL chloroform solution
containing 25 mg of EYPC under reduced pressure at 25°C, over 2 hours. The lipid
film was then hydrated with 750 μL of a NaCl (500 mM) and phosphate buffer
solution (5 mM, pH= 7.2). The resulting suspension was subjected to at least 8
freeze/thaw/vortex cycles (1 cycle = 1 min at -78°C, followed by 1 min at 35°C, and
1 min in vortex). The solution was then extruded through a 100 nm polycarbonate
membrane 21 times until the solution was transparent. The resulting solution was
passed down a Sephadex G-25 column to remove any extravesicular NaCl. The
liposomes were eluted with a solution containing NaNO3 (500 mM) and phosphate
buffer (5 mM, pH=7.2). 3.2 mL of liposome solution were isolated after separation
and the stock solution was diluted to obtain a 5 mM lipid solution, assuming all EYPC
was incorporated into the liposomes.
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3.25 Chloride Transport Assays with EYPC LUVs
A solution of EYPC LUVs (60 μL, 5 mM) was added to a 1.2 mL gently stirred buffer
solution containing NaNO3 (500 mM) and phosphate buffer (5 mM, pH= 7.2). The
chloride efflux was monitored as a function of time by a chloride selective-electrode.
Experiments were initiated by the addition of a small amount of a DMSO solution of
the respective transporter with concentrations varied from 6.25 to 25 mol% relative
to the concentration of EYPC. At t= 540 s, 100 μL of a Triton-X 5% solution was
added to lyse all liposomes and obtain the maximum of chloride efflux. Experiments
were repeated in triplicate and all the reported traces are the average of the three
identical trials.

3.26 Conversion of chloride concentration data into % of chloride efflux
Each transport assay curve is normalized using the following equation:

%𝐶𝑙𝑒𝑓𝑓𝑙𝑢𝑥
With

[𝐶𝑙 − ] − [𝐶𝑙 − ]0
=
× 100
[𝐶𝑙 − ]𝑚𝑎𝑥 − [𝐶𝑙 − ]0

[𝐶𝑙 − ] = Chloride efflux
[𝐶𝑙 − ]0 = chloride efflux at initial time
[𝐶𝑙 − ]𝑚𝑎𝑥 = chloride efflux at the end of experiment
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